Rezolute (RZLT) Capital Leases (2014 - 2015)

Rezolute (RZLT) reported Capital Leases of $23127.0 for Q2 2015, down 50.74% sequentially from $46946.0 in Q1 2015.

Rezolute (RZLT) Capital Leases (2014 - 2015) Analysis & Trends

Rezolute (RZLT) has 2 years of Capital Leases data on file, last reported at $23127.0 in Q2 2015.

For the quarter ending Q2 2015, Capital Leases changed N/A year-over-year to $23127.0; the trailing twelve-month figure through Jun 2015 stood at $23127.0 (changed N/A YoY), and the FY2015 full-year result was $23127.0, changed N/A from the prior year.
Capital Leases declined to $23127.0 in Q2 2015, from $46946.0 in the prior quarter.
In the past five years, Capital Leases ranged from a high of $101695.0 in Q3 2014 to a low of $23127.0 in Q2 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Rezolute	31,153.77	31,153.77	-

Historic Data

Download Data

Date	Value
Jun 30, 2015	23,127.00
Mar 31, 2015	46,946.00
Dec 31, 2014	70,677.00
Sep 30, 2014	101,695.00